CLVT logo

Clarivate Plc Stock Price

NYSE:CLVT Community·US$1.6b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 18 Fair Values set on narratives written by author

CLVT Share Price Performance

US$2.53
-1.65 (-39.47%)
US$3.64
Fair Value
US$2.53
-1.65 (-39.47%)
30.4% undervalued intrinsic discount
US$3.64
Fair Value
Price US$2.53
AnalystConsensusTarget US$3.64
yiannisz US$4.21
AnalystLowTarget US$2.40

CLVT Community Narratives

·
Fair Value US$3.64 30.4% undervalued intrinsic discount

Global Pharma And AI Trends Will Build Future Growth

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
Fair Value
·
Fair Value US$4.21 39.9% undervalued intrinsic discount

Clarivate Stock: When Data Becomes the Backbone of Innovation and Law

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value US$2.4 5.4% overvalued intrinsic discount

Rising Regulatory Costs And Data Erosion Will Undermine Future Performance

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
US$4.21
39.9% undervalued intrinsic discount
Fair Value
Profit Margin
8.66%
Future PE
17.81x
Price in 2030
US$7.33

Trending Discussion

Updated Narratives

CLVT logo

Clarivate Stock: When Data Becomes the Backbone of Innovation and Law

Fair Value: US$4.21 39.9% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CLVT logo

CLVT: Free Cash Flow May Offset AI And Portfolio Execution Risks

Fair Value: US$3.64 30.4% undervalued intrinsic discount
4 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CLVT logo

CLVT: Life Sciences Sale Execution Will Drive Upside Despite AI Risk

Fair Value: US$6 57.8% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with moderate growth potential.

0 Risks
4 Rewards

Clarivate Plc Key Details

US$2.4b

Revenue

US$818.7m

Cost of Revenue

US$1.6b

Gross Profit

US$1.8b

Other Expenses

-US$137.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.21
66.54%
-5.62%
88.9%
View Full Analysis

About CLVT

Founded
1864
Employees
12000
CEO
Matitiahu Shem Tov
WebsiteView website
www.clarivate.com

Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Recent CLVT News & Updates

Narrative Update May 23

CLVT: Free Cash Flow May Offset AI And Portfolio Execution Risks

Analysts have trimmed Clarivate price targets into a roughly $2.40 to $6 range, citing concerns around AI-related disruption risks and execution questions on the planned Life Sciences and Healthcare unit sale, even as some highlight solid free cash flow performance and guidance. Analyst Commentary Recent research notes reflect a mixed but generally cautious stance on Clarivate, with most firms trimming price targets while keeping ratings unchanged.

Recent updates

No updates